Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCRIT for cognitive function in breast cancer
NCT00246597Phase 3Terminated
- Sponsor
- Ortho Biotech Inc.
- Start
- Dec 2002
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of epoetin alfa in chemotherapy-induced cognitive impairment (CICI), anemia, sponsored by Ortho Biotech Inc.. Started Dec 2002; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
chemotherapy-induced cognitive impairment (CICI)anemia
Beyond the preview
Go deeper on NCT00246597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246597.